APM
NERV icon

Avidity Partners Management’s Minerva Neurosciences NERV Stock Holding History

Avidity Partners Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-55,525
Closed -$2.67M – 74
2020
Q1 		$2.67M Buy
+55,525
New +$3.35M 0.37% 50

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Avidity Partners Management's NERV Position: Q2 2020 in Review

Avidity Partners Management sold out of Minerva Neurosciences (NERV) in Q2 2020, closing a stake of 55,525 shares — an estimated $2.67M sold.

Avidity Partners Management first reported a position in NERV in Q1 2020 and held it in 1 quarter. The position peaked at $2.67M in Q1 2020. 80 funds tracked by Wall St. Rank hold NERV as of Q2 2020.

  • Avidity Partners Management reported no remaining Minerva Neurosciences position as of Q2 2020 after selling out during the quarter.
  • Avidity Partners Management sold 55,525 Minerva Neurosciences shares in Q2 2020, an estimated $2.67M.
  • Avidity Partners Management first reported a position in Minerva Neurosciences in Q1 2020 and held it in 1 quarter.
  • Avidity Partners Management's Minerva Neurosciences position peaked at $2.67M in Q1 2020.
  • 80 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2020.

Based on Avidity Partners Management's 13F filing for Q2 2020, filed 14 Aug 2020.